The risk of precipitating a convulsion in epileptic patients with methohexitone has been judged to vary widely. This article reports such complications arising during methohexitoneactivated E.E.G. recording in a series of 48 epileptic patients from whom anticonvulsant medication was 'i.£,ithheld. Two patients developed grand mal convulsions during induction with methohexitone 1· 0%. Two others exhibited status epilepticus of the petit mal type and one of the myoclonic type, after stopping an infusion of 0 ·09% methohexitone. The specijicity for methohexitone-induced convulsions in epileptics or crypto-epileptics is supported by a review of the literature.
Nineteen hundred and seventy-seven marks the twenty-first anniversary of the introduction of the sodium salt of 1-methyl-5-allyl-5-(1methyl-2-pentanyl) barbituric acid to clinical anaesthetic practice. Even though the parent compound 22451 demonstrated convulsive features (Heaton 1956 , Gibson et al. 1959 ) the early awakening characteristic prompted further study of its stereo-isomers. Methohexitone (compound 25398) is the high melting point isomer of the IX-dl racemic form of compound 22451 and combines anaesthetic potency with rapid recovery but exhibits fewer excitatory features than other stereo-isomers (Stoelting 1957) .
The risk of precipitating a convulsion with methohexitone in a crypto-epileptic is widely recognized (Redish et al. 1958 , Goldman 1969 , Thornton 1970 , and has detracted from the routine use of methohexitone in general anaesthesia. Despite early reports (Heaton 1956 , Stoelting 1957 ) of convulsions in non-epileptics with the parent compound 22451, it is believed that methohexitone does not activate normal brain tissue to produce discharges, but only areas of cortical pathology. This characteristic is the rationale for its use by the clinical neurophysiologist to activate abnormal foci of electrocerebral discharges in the investigation of epilepsy (Gumpert and Paul 1971 , Hansotia, Singhal and Irani 1971 , Musella, Wilder and Schmidt 1971 , Andriola, Musella and Wilder 1971 , Hansotia and Berendes 1972 , Tong 1973 . This paper reports some complications of activation of the electro-encephalogram (E.E.G.) by methohexitone in epileptics, and discusses the implications for general anaesthesia with methohexitone.
METHOD
A retrospective survey was made of subjects who underwent methohexitone-activated E.E.G. recording between January 1970 and October 1975 at Plymouth General Hospital. Patients were selected for the investigation of suspected petit mal, temporal lobe epilepsy and behavioural disorders when conventional E.E.G. recording with hyperventilation and photic stimulation had failed to elicit localized discharges.
The nature and reason for the investigation were explained to the patient and consent given for the E.E.G. recording with insertion of sphenoidal electrodes under general anaesthesia. A 0 ·09% solution of methohexitone was freshly prepared by dissolving 500 mg of the powder in 50 ml of sterile water, and this was added to 500 ml of 0·9% sodium chloride. Twenty-three disc electrodes were applied with collodion to the scalp, using the Maudsely modification of the 10: 20 system and connected through a head box to a sixteen channel Elema-Schonander Mingograph. A routine resting E.E.G. was recorded with photic and hyperventilation stimulation as indicated by previous investigation and history.
On the first nine occasions, methohexitone was administered by intermittent injection of 10 mg increments of a 1·0% solution. Subsequently, methohexitone (0 ·09% solution) was infused intravenously at a rate of 0·7 mg/kg over the first millUte, reducing over the next five minutes to 0·07 mg/kg. The infusion rate was also adjusted according to the individual's E.E.G. response to produce slower wave forms with increasing depth of anaesthesia, avoiding, if possible, the stage of burst-suppression patterns (Dundee and Wyant 1974) .
The sphenoidal electrodes (23 g xlt" insulated needles) were inserted percutaneously between the ramus of the mandible and the zygomatic arch to lie ur,der the foramen ovale. This often required a brief increase in the depth of anaesthesia. Nasopharyngeal electrodes were passed through the nares, lubricated with lignocaine jelly, so that the recording tips engaged the posterior naso-pharyngeal wall.
The duntion of the methohexitone administration varied with the appearance of new information on the E.E.G. tracing. The patient was allowed to emerge from anaesthesia slowly and without stimulation except when a loud clap was thought useful to provoke the discharge of a focus. Recording was continued for as long as the clinical condition of the patient indicated, or until the E.E.G. had returned to the pattern before investigation.
Forty-eight patients underwent methohexitone-activated E.E.G. analysis on fifty-two occasions with four having repeat investigation. Twenty-seven patients had suffered grand mal attacks, and thirty-one experienced focal, centrencephalic or myoclonic phenomena. Three other cases were of proven organic disorders of cerebrovascular or brain-stem origin. The ages ranged from 6 to 65 years with 56% Of the patients between 15 and 29 years of age. Males outnumbered females by 27 to 21.
RESULTS
On the first nine occasions when the methohexitone was administered by intermittent injection, two patients developed limb twitching and sneezing which hampered E.E.G. recording and two other patients developed grand mal convulsions.
In the thirty-seven patients given the continuous infusion of methohexitone, three developed status epilepticus, two of the petit mal type, and one of myoclonic jerks. Two patients showed excitatory phenomena with twitching of the hands and face. Three patients exhibited burst-suppression patterns on the E.E.G. after receiving approximately 80 mg of methohexitone over a period of 5 to 10 minutes, and were accordingly diagnosed as suffering organic brain disease due to cerebrovascular insufficiency. Clinically, the patients did not show signs of deep anaesthesia, and were able to maintain their airway and regain consciousness within five minutes.
With the exception of the two cases of grand mal and two of status petit mal, all other patients in this study showed a return of consciousness within five minutes of stopping the methohexitone. This was surprising in view of the large total dose administered (up to 500 mg) albeit over a long period of time (up to 60 minutes).
A elinical impression was gained that patients exhibiting classical petit mal type spike-andwave activity in the resting E.E.G. lost this pattern during the administration of methohexitone which produced stage II sleep, but it returned with a greater intensity after initial recovery of consciousness. In some patients localized spike discharges from the temporal lobe were recorded only from the sphenoidal electrodes during the methohexitone infusion. In the majority of patients increased spike activity was recorded during the early recovery period. These discharges gradually became less prominent as complete alertness was regained.
DISCUSSION
The risk of precipitating epilepsy with methohexitone has been judged to vary widely. From five reports (Galley 1966 , Goldman 1969 , Boston and Unkles 1969 , Ryder 1969 , Mann 1971 ) of grand mal attacks during methohexitone anaesthesia in the dental chair, Thornton (1970) proposed that it would be unwise to administer the agent when a history of epilepsy is elicited in either the patient, his parents or siblings. With an estimate of the prevalence of epilepsy in the general population of 0·5 %, this restriction would apply to 1 in 40 patients. In a study of 595 patients undergoing conservative dentistry employing a minimal increment methohexitone technique (Mann et al. 1971) , the only patient who developed an epileptiform attack during the administration of a 1· 0% methohexitone gave no previous history of fits. Unfortunately the records of this case have been lost to follow-up and the results of the E.E.G. recording are not known (Mann 1975) . Ryder (1969) relates details of a 20-year-old patient undergoing gynaecological surgery who had an epileptiform seizure following 70 mg of methohexitone. Again there was no history of epilepsy, but neither was an epileptic diathesis excluded by a post-operative E.E.G. recording. These reports of epileptiform seizures during methohexitone anaesthesia in two young adult females without a previous history of epilepsy must be contrasted with seven cases with an epileptic diathesis (Galley 1963 and 1966 , Goldman 1969 , Boston and Unkles 1969 , Ryder 1969 , Redish et al. 1958 , three of whom gave a history of grand mal epilepsy, and four in whom E.E.G. recordings revealed dysrhythmias or focal discharge.
In contrast to warnings of precipitating an epileptiform attack in a known or cryptoepileptic, there are several reports disputing these risks. In a review of the pharmacology of methohexitone, Whitwan (1972) stated that methohexitone is not contraindicated in epileptic patients. For dental practice, Moreland, Sture and Wood (1969) believed that methohexitone was the drug of choice for general anaesthesia in epileptic subjects. The choice of an alternative intravenous induction agent to methohexitone for epileptics attending as outpatients has been made more difficult by recent reports of convulsions with propanidid (Barron 1974 ) and althesin (Uppington 1973 , Rees 1975 . Only one of these five cases was a known epileptic, two were investigated and shown to have an epileptic diathesis, one showed no E.E.G. abnormality and the other was lost to follow-up.
It is interesting to note in our study that grand mal convulsions were precipitated by the intermittent intravenous injection of methohexitone 1'0% in two of only three patients with a history of grand mal epilepsy. However intravenous infusion of the O· 09% solution failed to precipitate such complications in sixteen other patients with a similar history. Alas, numbers were too small to achieve statistical significance. In support of this bias, of thirteen reported cases of grand mal convulsions during methohexitone anaesthesia (Heaton 1956 , Redish et al. 1958 , Goldman 1969 , Galley 1963 and 1966 , Ryder 1969 , Mann et al. 1971 , Hunter 1972 all but one were given the agent by intermittent injection of a 1% or stronger solution. The exception was reported by Hunter (1972) with the patient undergoing intracranial surgery under 0·1 % infusion with small doses of curare.
During this study, the change in technique of methohexitone administration, from intermittent intravenous injection of the 1·0% solution to continuous infusion of the weaker 0 . 09% solution, was prompted by several observations. The latter method offered a much finer control of the depth of anaesthesia as indicated by the E.E.G. (Dundee and Wyant 1974) . Intermittent injection of the stronger solution readily produced burst-suppression with rapid passage through patterns of high amplitUde, fast spiky activity of mixed frequencies, and slower wave forms I of irregular content and random occurrences in which localized spike discharges were most frequently elicited. The intermittent injection technique also precipitated ex citatory phenomena, for example hiccup and twitching of the limbs, which interrupted the E.E.G. recording with mechanical artefact. The continuous infusion did not produce these doserelated phenomena (Barron and Dundee 1967) so frequently, nor were they so troublesome during recording.
The infusion of 0 . 09 % methohexitone precipitated status epilepticus of the petit mal type in two patients. Gibberd (1972) confines the term petit mal status to those patients who have status epilepticus in which the seizures have the characteristic of petit mal. Both our cases exhibited episodes of unresponsiveness following initial recovery accompanied by classical 3 per second spike-and-wave activity (Figure 1 ). These recurred frequently over a period of 20 to 25 minutes after early recovery and were terminated by intravenous acetazolamide and ethosuximide by mouth given during a conscious interval. Prior to the investigation, both patients had experienced increasingly frequent minor and major attacks, the nature of which was uncertain.
A review of petit mal status epilepticus (Lipman, Isaacs and Suter 1971) suggests that only 3% of patients with petit mal epilepsy will experience petit mal status. It may present as an acute confusional state in middle age (Schwartz and Scott 1971) . Petit mal seizures have been reported previously following methohexitone (Heaton 1956 ), though the diagnosis was not substantiated by an E.E.G. recording. Indeed Galley (1966) describes an adult who gave a typical history of petit mal during early childhood having seven episodes of unconsciousness in 35 minutes after initial recovery from nitrous oxide and oxygen administered for dental extractions. Delayed or incomplete recovery from methohexitone anaesthesia could be attributed to petit mal epilepsy; petit mal status could only be confirmed by an E.E.G. recording which may not be readily available.
In the likelihood of such arising in a patient with a previous history of petit mal, the administration of 500 mg ethosuximide by mouth could support the diagnosis, since this drug is effective in true petit mal but not other forms of epilepsy. Precipitation by methohexitone of status epilepticus of the myoclonic type has not been previously described, though the myoclonic twitching and involuntary movements associated with its use are frequently seen (Barron and Dundee 1967) . The E.E.G. studies (Vickers 1963) of patients receiving methohexitone, however, have not revealed any evidence of a localized cortical discharge coincidental with these movements, which are believed to arise at brain-stem or subcortical levels. CONCLUSION Methohexitone may precipitate an epileptic attack in those patients with a history of grand mal, petit mal or myoclonic epilepsy, particularly if the patient is fasting and the anticonvulsant medication has been discontinued or is exerting little clinical control. It seems unlikely that such a complication will arise if the patient receives the usual anticonvulsant therapy prior to anaesthesia and surgery. Improved pre-operative assessment may identify those crypto-epileptics with a past history of petit mal in childhood, or head injury, who may be more likely to suffer an attack during or after methohexitone anaesthesia. Thiopentone remains the intravenous induction agent of choice for the epileptic. Since convulsions have been reported in non-epileptics as well as epileptics with propanidid (Barron 1974 ) and althesin (Uppington 1973 , Rees 1975 , these agents offer no advantage over methohexitone for outpatient surgery on crypto-epileptics. reviewing E.E.G. records, and Elizabeth Hurst for the photograph of the E.E.G. tracing. Mrs. Joyce Kimpton and Miss Joan Larsen provided secretarial assistance. Eli Lilly & Co. Limited kindly assisted with the literature search.
